CEL-SCI Reports 73.4% Five-Year Survival With Multikine in Biomarker-Selected Head and Neck Cancer Patients

Bitget2026/10/26 12:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CEL-SCI presented new analyses from its completed Phase 3 Multikine study at the World Congress on Otology, Rhinology and Laryngology in Rome.
Multikine improved survival versus standard care alone in selected head and neck cancer patients receiving treatment before surgery.
Patients without lymph node involvement and with low or no tumor PD-L1 expression showed the strongest survival benefit.
Pre-surgical treatment increased tumor responses without increasing severe adverse events; no deaths were attributed to Multikine.
The findings underpin an upcoming 212-patient U.S. registration study designed to prospectively confirm the results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CEL-SCI Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202610260800BIZWIRE_USPR_____20261026_BW718879) on October 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03

Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.

On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.

华尔街见闻•2026/11/10 23:01